On the other hand, MEN2b accounts for approximately 5–10% of all MEN2 cases and is marked by an early onset of a more aggressive form of MTC developing within the first year of life, with a maximum survival age of 30 years [179]. This evidence concerns the gene RET and medullary thyroid gland carcinoma.